Avaliação dos níveis de citocinas e da função pulmonar de pacientes submetidos à cirurgia cardíaca com circulação extracorpórea
Evaluation of cytokine levels and pulmonary function in patients undergoing coronary artery bypass graft
Luciano Brandão Machado; Elnara Marcia Negri; Wanderley Wesley Bonafé; Luciana Moraes Santos; Luís Marcelo Sá Malbouisson; Maria José Carvalho Carmona
Resumo
Palavras-chave
Abstract
Keywords
Referências
Hall RI, Smith MS, Rocker G. The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacological considerations. Anesth Analg. 1997;85:766-782.
Kollef MH, Wragge T, Pasque C. Determinants of mortality and multiorgan dysfunction in cardiac surgery patients requiring prolonged mechanical ventilation. Chest. 1995;107:1395-1401.
Cotran RS, Kumar V, Robins SL. Inflammation and Repair. Robbins Pathologic Basis of Disease. 1994:51-94.
Laffey JG, Boylan JF, Cheng DC. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology. 2002;97:215-252.
Gerlach H, Keh D. Sepsis in 2003: are we still in the middle of nowere?. Curr Opin Anaesthesiol. 2004;17:97-106.
Bennett-Guerrero E. Systemic Inflammation. Cardiac Anesthesia. 1999:297-318.
Loisa P, Rinne T, Laine S. Anti-inflammatory cytokine response and the development of multiple organ failure in severe sepsis. Acta Anaesthesiol Scand. 2003;47:319-325.
Brix-Christensen V. The systemic inflammatory response after cardiac surgery with cardiopulmonary bypass in children. Acta Anaesthesiol Scand. 2001;45:671-679.
Brix-Christensen V, Vestergaard C, Chew M. Plasma cytokines do not reflect expression of pro- and anti-inflammatory cytokine mRNA at organ level after cardiopulmonary bypass in neonatal pigs. Acta Anaesthesiol Scand. 2003;47:525-531.
Crestani B, Cornillet P, Dehoux M. Alveolar type II epithelial cells produce interleukin-6 in vitro and in vivo: Regulation by alveolar macrophage secretory products. J Clin Invest. 1994;94:731-740.
Friedman M, Sellke FW, Wang SY. Parameters of pulmonary injury after total or partial cardiopulmonary bypass. Circulation. 1994;90(5):II262-268.
Massoudy P, Zahler S, Becker BF. Evidence for inflammatory responses of the lungs during coronary artery bypass grafting with cardiopulmonary bypass. Chest. 2001;119:31-36.
Higgins TL, Estafanous FG, Loop FD. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients: A clinical severity score. Jama. 1992;267:2344-2348.
Crystal RG, Reynolds HY, Kalica AR. Bronchoalveolar lavage: The report of an international conference. Chest. 1986;90:122-131.
Crespo A, Carvalho AF. Capnografia. Monitorização Respiratória em UTI. 1998:283-298.
Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples). Biometrika. 1965;52:591-611.
Rosner B. Fundamentals of Biostatistics. 1986:575-579.
Winer BJ. Statistical Principles in Experimental Design. 1971.
Goldman L, Hashimoto B, Cook EF. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation. 1981;64:1227-1234.
Wan S, DeSmet JM, Barvais L. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1996;112:806-811.
Oberholzer A, Oberholzer C, Moldawer LL. Cytokine signaling regulation of the immune response in normal and critically ill states. Crit Care Med. 2000;28(4^ssuppl):N3-12.
Prondzinsky R, Knupfer A, Loppnow H. Surgical trauma affects the proinflammatory status after cardiac surgery to a higher degree than cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2005;129:760-766.
Babik B, Asztalos T, Petak F. Changes in respiratory mechanics during cardiac surgery. Anesth Analg. 2003;96:1280-1287.
Machado LB, Santos LM, Negri EM. Broncho-alveolar lavage cellularity in patients submitted to myocardial revascularization with cardiopulmonary bypass: three case reports. Rev Bras Anestesiol. 2006;56:263-272.
Landis RC. Redefining the systemic inflammatory response. Semin Cardiothorac Vasc Anesth. 2009;13:87-94.
Levy JH, Tanaka KA. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 2003;75:S715-720.
Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg. 2002;21:232-244.
Fillinger MP, Rassias AJ, Guyre PM. Glucocorticoid effects on the inflammatory and clinical responses to cardiac surgery. J Cardiothorac Vasc Anesth. 2002;16:163-169.
Webster NR, Galley HF. Immunomodulation in the critically ill. Br J Anaesth. 2009;103:70-81.
Niemann JT, Youngquist S, Rosborough JP. Infliximab attenuates early myocardial dysfunction after resuscitation in a swine cardiac arrest model. Crit Care Med. 2010;38:1162-1167.
Tomasdottir H, Hjartarson H, Ricksten A. Tumor necrosis factor gene polymorphism is associated with enhanced systemic inflammatory response and increased cardiopulmonary morbidity after cardiac surgery. Anesth Analg. 2003;97:944-949.
Galley HF, Lowe PR, Carmichael RL. Genotype and interleukin-10 responses after cardiopulmonary bypass. Br J Anaesth. 2003;91:424-426.
Lin MT, Albertson TE. Genomic polymorphisms in sepsis. Crit Care Med. 2004;32:569-579.
Bilgin YM, van de Watering LMG, Versteegh MIM. Effects of allogeneic leukocytes in blood transfusions during cardiac surgery on inflammatory mediators and postoperative complications. Crit Care Med. 2010;38:546-552.